Gene G. Olinger

10.2k total citations · 2 hit papers
91 papers, 5.8k citations indexed

About

Gene G. Olinger is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gene G. Olinger has authored 91 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Infectious Diseases, 23 papers in Epidemiology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gene G. Olinger's work include Viral Infections and Outbreaks Research (67 papers), Viral Infections and Vectors (38 papers) and SARS-CoV-2 and COVID-19 Research (22 papers). Gene G. Olinger is often cited by papers focused on Viral Infections and Outbreaks Research (67 papers), Viral Infections and Vectors (38 papers) and SARS-CoV-2 and COVID-19 Research (22 papers). Gene G. Olinger collaborates with scholars based in United States, Canada and United Kingdom. Gene G. Olinger's co-authors include Lisa E. Hensley, Peter B. Jahrling, Julie Dyall, Kelly L. Warfield, Matthew B. Frieman, Lisa M. Johansen, Reed F. Johnson, Jason Kindrachuk, Sina Bavari and Calli M. Lear-Rooney and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gene G. Olinger

91 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

2014 475 citations Julie Dyall, Brit J. Hart et al. Antimicrobial Agents and Chemotherapy profile →
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis

2014 307 citations Jason Kindrachuk, Brit J. Hart et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Gene G. Olinger

EPIDE

IMMUN

EMS

Andrea Marzi United States

Friederike Feldmann United States

Dana Scott United States

John W. Huggins United States

Yousuke Furuta Japan

Travis K. Warren United States

Darryl Falzarano Canada

Peter Halfmann United States

John S. Tregoning United Kingdom

Darwyn Kobasa Canada

Andrea Marzi United States

Gene G. Olinger

6.7k ×1.6

2.5k ×1.6

EPIDE

1.1k ×1.1

880 ×1.3

IMMUN

478 ×0.9

EMS

Citations per year, relative to Gene G. Olinger Gene G. Olinger (= 1×) peers Andrea Marzi

Countries citing papers authored by Gene G. Olinger

Since Specialization

Citations

This map shows the geographic impact of Gene G. Olinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gene G. Olinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gene G. Olinger more than expected).

Fields of papers citing papers by Gene G. Olinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gene G. Olinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gene G. Olinger. The network helps show where Gene G. Olinger may publish in the future.

Co-authorship network of co-authors of Gene G. Olinger

This figure shows the co-authorship network connecting the top 25 collaborators of Gene G. Olinger. A scholar is included among the top collaborators of Gene G. Olinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gene G. Olinger. Gene G. Olinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shittu, Ismaila, Diego Augusto Santos Silva, Judith U. Oguzie, et al.. (2024). A One Health Investigation into H5N1 Avian Influenza Virus Epizootics on Two Dairy Farms. Clinical Infectious Diseases. 80(2). 331–338. 12 indexed citations

Parekh, Falgunee K., Illich Manfred Mombo, Roger Hewson, et al.. (2023). Climate change and infectious disease: A prologue on multidisciplinary cooperation and predictive analytics. Frontiers in Public Health. 11. 1018293–1018293. 4 indexed citations

Armstrong, Derek T., et al.. (2021). SARS-CoV-2 Supply Shortages and Tuberculosis Diagnostics: Current Issues Requiring Immediate Solutions. Journal of Clinical Microbiology. 59(12). e0077821–e0077821. 4 indexed citations

Wagoner, Jessica, Elizabeth A. Nelson, Qinfeng Huang, et al.. (2021). Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs. Antimicrobial Agents and Chemotherapy. 65(4). 30 indexed citations

White, Judith M., Joshua T. Schiffer, Rachel Bender Ignacio, et al.. (2021). Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 12(6). e0334721–e0334721. 42 indexed citations

Michelotti, Julia, et al.. (2021). First Movers in Molecular Detection: Case Comparison on Harnessing Research and Development, Industry, and Entrepreneurship. Frontiers in Medicine. 8. 639440–639440. 2 indexed citations

Bruchez, Anna, Joshua C. Johnson, Li Chen, et al.. (2020). MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science. 370(6513). 241–247. 71 indexed citations

Abdulla, Aynur, Qian Feng, Theodore Kee, et al.. (2020). Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention. Advanced Therapeutics. 3(7). 2000034–2000034. 43 indexed citations

Parekh, Falgunee K., et al.. (2020). Infectious Disease Risks and Vulnerabilities in the Aftermath of an Environmental Disaster in Minas Gerais, Brazil. Vector-Borne and Zoonotic Diseases. 20(5). 387–389. 7 indexed citations

10.

Dyall, Julie, Lisa Evans DeWald, Steven R. King, et al.. (2019). Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin. PLoS neglected tropical diseases. 13(7). e0007595–e0007595. 34 indexed citations

11.

Postnikova, Elena, Yu Cong, Lisa Evans DeWald, et al.. (2018). Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs. PLoS ONE. 13(3). e0194880–e0194880. 32 indexed citations

12.

Honko, Anna N., Joshua C. Johnson, Louis Huzella, et al.. (2017). High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona. Scientific Reports. 7(1). 5886–5886. 15 indexed citations

13.

Bennett, Richard S., Louis Huzella, Peter B. Jahrling, et al.. (2017). Nonhuman Primate Models of Ebola Virus Disease. Current topics in microbiology and immunology. 411. 171–193. 32 indexed citations

14.

Kindrachuk, Jason, Brit J. Hart, Steven Mazur, et al.. (2014). Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis. Antimicrobial Agents and Chemotherapy. 59(2). 1088–1099. 307 indexed citations breakdown →

15.

Michelow, Ian C., Mingdong Dong, Bruce A. Mungall, et al.. (2010). A Novel L-ficolin/Mannose-binding Lectin Chimeric Molecule with Enhanced Activity against Ebola Virus. Journal of Biological Chemistry. 285(32). 24729–24739. 50 indexed citations

16.

Warfield, Kelly L., Dana L. Swenson, Gene G. Olinger, et al.. (2007). Ebola Virus‐Like Particle–Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge. The Journal of Infectious Diseases. 196(s2). S430–S437. 210 indexed citations

17.

Mohamadzadeh, Mansour, Lieping Chen, Gene G. Olinger, William D. Pratt, & Alan Schmaljohn. (2006). Filoviruses and the Balance of Innate, Adaptive, and Inflammatory Responses. Viral Immunology. 19(4). 602–612. 21 indexed citations

18.

Warfield, Kelly L., Gene G. Olinger, Emily M. Deal, et al.. (2005). Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection. The Journal of Immunology. 175(2). 1184–1191. 119 indexed citations

19.

Olinger, Gene G., Mohammed Saifuddin, Melanie L. Hart, & Gregory T. Spear. (2002). Cellular Factors Influence the Binding of HIV Type 1 to Cells. AIDS Research and Human Retroviruses. 18(4). 259–267. 12 indexed citations

20.

Spear, Gregory T., Melanie L. Hart, Gene G. Olinger, Farhad B. Hashemi, & Mohammed Saifuddin. (2001). The Role of the Complement System in Virus Infections. Current topics in microbiology and immunology. 260. 229–245. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact